Clinical Trials Update: Dec. 8, 2010
Menstrual Migraines Insomnia Pulmonary Arterial Hypertension (PAH)
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study will evaluate the safety and effectiveness of an investigational hormone contraceptive to treat menstrual migraines. The study will consist of five visits over about 20 weeks.
The research site is in Seattle, Wash.
This study will evaluate a non-invasive device for insomnia. It will last up to eight weeks, involving two office visits and four overnight stays.
The research site is in Glendale, Calif.
Pulmonary Arterial Hypertension (PAH)
This study is for people with pulmonary arterial hypertension, a rare and debilitating condition that causes high blood pressure in lung blood vessels. Symptoms may include shortness of breath, fatigue, chest pain and rapid heartbeat.
The research site is in Boston, Mass.
Copyright 2010 ClinicalConnection.com. All rights reserved.